Structural Heart Occlusion Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Structural Heart Occlusion Devices Market Report Overview

The structural heart occlusion devices market was valued at $3.78 billion in 2023. The market is expected to grow at a CAGR of more than 7% from 2023 to 2033. Structural heart occluders are used for the treatment of structural heart diseases, most of which are congenital. With technological advancements, such as the invention of structural heart occluders, most children with CHDs are now expected to reach adulthood.

Structural Heart Occlusion Devices Market Outlook 2023-2033 ($ Billion)

Buy the Full Report for Detailed Insights on the Structural Heart Occlusion Devices Market Forecast,
Download a Free Sample Report

The structural heart occlusion devices market research report provides a comprehensive insight into the market trends within cardiovascular devices therapeutic areas. The model discusses in detail the impact of COVID-19 on the structural heart occlusion devices market for the year 2020 and beyond.

Structural Heart Occlusion Devices Market Dynamics

The market for structural heart occluders has been expanding as there is an increased population of older adults living with CHDs. The growing preference for minimally invasive surgeries, the rise in R&D spending for the development of novel and technologically advanced products, and the increase in demand for highly effective procedures are all factors that contribute to the growth of the structural heart devices market. However, it is anticipated that market expansion in the next years might be constrained by low cardiac surgery accessibility and cost in underdeveloped nations.

Structural Heart Occlusion Devices Market Segments

The key segments in the structural heart occlusion devices market are Atrial Septal Defect Occluders, Left Atrial Appendage Closure Devices, Patent Ductus Arteriosus Closure Devices, Patent Foramen Ovale Closure Devices, Ventricular Septal Defect Occluders. In 2023, the Left Atrial Appendage Closure Devices segment dominated the market share. Left Atrial Appendage Implanted Occlusion Devices and Left Atrial Appendage Ligation Devices are the key sub-segments of the structural heart occlusion devices market. Of these, Left Atrial Appendage Implanted Occlusion Devices dominated the market share.

Structural Heart Occlusion Devices Market Analysis by Segments, 2023 (%)

Buy the Full Report for Segment-Specific Revenues and Shares
Download a Free Sample Report

Structural Heart Occlusion Devices Market Segmentation by Regions

The key regions in the structural heart occlusion devices market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America had the largest share of the structural heart occlusion devices market and is expected to retain its position throughout the forecast period.

This region has a significant proportion of the worldwide market due to factors including the increased incidences of structural heart disorders and the attractive reimbursement environment for cardiac surgeries and devices. Furthermore, technical breakthroughs, the presence of key market players, and the creation of novel technologies are few other factors anticipated to drive the market’s growth during the projected period.

Structural Heart Occlusion Devices Market Analysis by Regions, 2023 (%)

Buy the Full Report for more Regional Insights into the Structural Heart Occlusion Devices Market, Download a Free Sample Report

Structural Heart Occlusion Devices Market – Competitive Landscape

The key companies in the structural heart occlusion devices market are Boston Scientific Corp, Abbott Laboratories, AtriCure Inc, Lifetech Scientific Corporation, Occlutech GmbH, pfm medical ag, W. L. Gore & Associates Inc, and Others. In 2023, Boston Scientific Corp accounted for the highest structural heart occlusion devices market share and value.

Structural Heart Occlusion Devices Market Analysis by Companies, 2023 (%)

Buy the Full Report to Know More About Leading Structural Heart Occlusion Devices Market Players
Download a Free Sample Report

Segments Covered in this Report

Structural Heart Occlusion Devices Segment Outlook ($ Million, 2015-2033)

• Atrial Septal Defect Occluders
• Left Atrial Appendage Closure Devices
  • Left Atrial Appendage Implanted Occlusion Devices
  • Left Atrial Appendage Ligation Devices
• Patent Ductus Arteriosus Closure Devices
• Patent Foramen Ovale Closure Devices
• Ventricular Septal Defect Occluders

Structural Heart Occlusion Devices Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are –

Currently marketed structural heart occlusion devices market and evolving competitive landscape –

• Insightful review of the key industry trends.
• Annualized total structural heart occlusion devices market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights –

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Structural heart occlusion devices market.
• Competitive dynamics insights and trends provided for the structural heart occlusion devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Abbott Laboratories, AtriCure Inc, Lifetech Scientific Corporation, Occlutech GmbH, pfm medical ag, W. L. Gore & Associates Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for

• CMO executives who must have a deep understanding of the Structural heart occlusion devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
• Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

• Understand the impact of COVID-19 on structural heart occlusion devices.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving structural heart occlusion devices.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the structural heart occlusion devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific structural heart occlusion devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.